Correlation between Skip N2 Metastases and SUVmax, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer
Background. We aim at investigating the correlation between skip N2 metastases (SN2) and SUVmax, long diameter of tumor mass after 18F-FDG PET/CT, and pathological Ki67 expression in patients with non-small-cell lung cancer (NSCLC). Methods and Results. We retrospectively analyzed the factors that m...
Gespeichert in:
| Veröffentlicht in: | BioMed research international 2020, Vol.2020 (2020), p.1-7, Article 9298358 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7 |
|---|---|
| container_issue | 2020 |
| container_start_page | 1 |
| container_title | BioMed research international |
| container_volume | 2020 |
| creator | Jun, Zhao Long-bao, Xu Ming-ya, Peng Jian, Wang Shao, Guoqiang |
| description | Background. We aim at investigating the correlation between skip N2 metastases (SN2) and SUVmax, long diameter of tumor mass after 18F-FDG PET/CT, and pathological Ki67 expression in patients with non-small-cell lung cancer (NSCLC). Methods and Results. We retrospectively analyzed the factors that might affect the pathogenesis of SN2 in these patients. The clinical SN2 symptoms in patients with squamous carcinoma or adenocarcinoma were investigated. The work curve was utilized to analyze the optimal cutoff value for the SUVmax and long diameter of tumor. Multivariate analysis revealed that high expression of Ki67 was a risk factor for mediastinal SN2 (OR=1.042, 95% CI: 1.009-1.076). Subgroup analysis indicated that the SUVmax of the non-SN2 group was significantly higher than that of the SN2 group in patients with squamous carcinoma (16.3±6.0 vs. 10.7±5.6, P=0.026). In the patients with adenocarcinoma, the long diameter of tumor in the SN2 group was significantly longer than that of the non-SN2 group (43.8±16.3 mm vs. 30.1±13.8 mm, P=0.032). The Ki67 expression in the SN2 group was significantly higher than that of the non-SN2 group (51.7±24.0 vs. 30.0±19.2, P=0.028). Conclusions. The differences of clinical features of the patients in the SN2 group and non-SN2 group in the NSCLC patients were associated with the pathological subtypes, which were featured by lower SUVmax in the SN2 of the squamous carcinoma, and longer diameter of SN2 in the adenocarcinoma patients. |
| doi_str_mv | 10.1155/2020/9298358 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_proquest_miscellaneous_2404382398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2400274719</sourcerecordid><originalsourceid>FETCH-LOGICAL-e368t-820670d237cee880e6dde83302c231cf7b3fd323431fea8367fda447a25b076b3</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxSMEotXSG2dkiQsSDbU9SexckFAoBbEUpG25Rk4y6bok9mI7bPsV-NR4_2grOGFZsiX_5mme3yTJc0bfMJbnZ5xyelbyUkIuHyXHHFiWFixjjw93gKPkxPtbGpdkBS2Lp8kR8IxTkNlx8ruyzuGggraGNBjWiIYsfugVueTkCwbl40ZPlOnI4vr7qO5OydyaG_JeqxEDOmJ7cjWN1p1umc-6EOT8buXQ-42kNuRbFEcTPFnrsCSX1qSLUQ1DWuEwkPkUtSplWnTPkie9Gjye7M9Zcv3h_Kr6mM6_Xnyq3s1ThEKGVHJaCNpxEC2ilBSLrkMJQHkbLbe9aKDvgEMGrEcloRB9p7JMKJ43VBQNzJK3O93V1IzYtbE3p4Z65fSo3H1tla7_fjF6Wd_YX7XglAkBUeDVXsDZnxP6UI_at9GNMmgnX_OMZiA5xFRmyct_0Fs7ORPtbSjKRSZYGSm5o9bY2N638btaPDQUg8sBeJmX2wwrHbZpVXYyIZa-_v_SB3qpTafW-gAyWm_mqd7MU72fp0i_2NEYGezVA81A0lzAH5blwfU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2400274719</pqid></control><display><type>article</type><title>Correlation between Skip N2 Metastases and SUVmax, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer</title><source>PubMed Central Open Access</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Jun, Zhao ; Long-bao, Xu ; Ming-ya, Peng ; Jian, Wang ; Shao, Guoqiang</creator><contributor>Kafle, Kumud K. ; Kumud K Kafle</contributor><creatorcontrib>Jun, Zhao ; Long-bao, Xu ; Ming-ya, Peng ; Jian, Wang ; Shao, Guoqiang ; Kafle, Kumud K. ; Kumud K Kafle</creatorcontrib><description>Background. We aim at investigating the correlation between skip N2 metastases (SN2) and SUVmax, long diameter of tumor mass after 18F-FDG PET/CT, and pathological Ki67 expression in patients with non-small-cell lung cancer (NSCLC). Methods and Results. We retrospectively analyzed the factors that might affect the pathogenesis of SN2 in these patients. The clinical SN2 symptoms in patients with squamous carcinoma or adenocarcinoma were investigated. The work curve was utilized to analyze the optimal cutoff value for the SUVmax and long diameter of tumor. Multivariate analysis revealed that high expression of Ki67 was a risk factor for mediastinal SN2 (OR=1.042, 95% CI: 1.009-1.076). Subgroup analysis indicated that the SUVmax of the non-SN2 group was significantly higher than that of the SN2 group in patients with squamous carcinoma (16.3±6.0 vs. 10.7±5.6, P=0.026). In the patients with adenocarcinoma, the long diameter of tumor in the SN2 group was significantly longer than that of the non-SN2 group (43.8±16.3 mm vs. 30.1±13.8 mm, P=0.032). The Ki67 expression in the SN2 group was significantly higher than that of the non-SN2 group (51.7±24.0 vs. 30.0±19.2, P=0.028). Conclusions. The differences of clinical features of the patients in the SN2 group and non-SN2 group in the NSCLC patients were associated with the pathological subtypes, which were featured by lower SUVmax in the SN2 of the squamous carcinoma, and longer diameter of SN2 in the adenocarcinoma patients.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2020/9298358</identifier><identifier>PMID: 32420384</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adenocarcinoma ; Biomedical research ; Biotechnology & Applied Microbiology ; Life Sciences & Biomedicine ; Lung cancer ; Lymphatic system ; Medical imaging ; Medicine, Research & Experimental ; Metastases ; Metastasis ; Multivariate analysis ; Non-small cell lung carcinoma ; Pathogenesis ; Positron emission tomography ; Research & Experimental Medicine ; Risk analysis ; Risk factors ; Science & Technology ; Small cell lung carcinoma ; Statistical analysis ; Subgroups ; Tumors</subject><ispartof>BioMed research international, 2020, Vol.2020 (2020), p.1-7, Article 9298358</ispartof><rights>Copyright © 2020 Wang Jian et al.</rights><rights>Copyright © 2020 Wang Jian et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2020 Wang Jian et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>3</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000533295900008</woscitedreferencesoriginalsourcerecordid><cites>FETCH-LOGICAL-e368t-820670d237cee880e6dde83302c231cf7b3fd323431fea8367fda447a25b076b3</cites><orcidid>0000-0002-3277-6933 ; 0000-0003-0262-3394</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201773/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201773/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,887,4026,27930,27931,27932,28255,53798,53800</link.rule.ids></links><search><contributor>Kafle, Kumud K.</contributor><contributor>Kumud K Kafle</contributor><creatorcontrib>Jun, Zhao</creatorcontrib><creatorcontrib>Long-bao, Xu</creatorcontrib><creatorcontrib>Ming-ya, Peng</creatorcontrib><creatorcontrib>Jian, Wang</creatorcontrib><creatorcontrib>Shao, Guoqiang</creatorcontrib><title>Correlation between Skip N2 Metastases and SUVmax, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer</title><title>BioMed research international</title><addtitle>BIOMED RES INT-UK</addtitle><description>Background. We aim at investigating the correlation between skip N2 metastases (SN2) and SUVmax, long diameter of tumor mass after 18F-FDG PET/CT, and pathological Ki67 expression in patients with non-small-cell lung cancer (NSCLC). Methods and Results. We retrospectively analyzed the factors that might affect the pathogenesis of SN2 in these patients. The clinical SN2 symptoms in patients with squamous carcinoma or adenocarcinoma were investigated. The work curve was utilized to analyze the optimal cutoff value for the SUVmax and long diameter of tumor. Multivariate analysis revealed that high expression of Ki67 was a risk factor for mediastinal SN2 (OR=1.042, 95% CI: 1.009-1.076). Subgroup analysis indicated that the SUVmax of the non-SN2 group was significantly higher than that of the SN2 group in patients with squamous carcinoma (16.3±6.0 vs. 10.7±5.6, P=0.026). In the patients with adenocarcinoma, the long diameter of tumor in the SN2 group was significantly longer than that of the non-SN2 group (43.8±16.3 mm vs. 30.1±13.8 mm, P=0.032). The Ki67 expression in the SN2 group was significantly higher than that of the non-SN2 group (51.7±24.0 vs. 30.0±19.2, P=0.028). Conclusions. The differences of clinical features of the patients in the SN2 group and non-SN2 group in the NSCLC patients were associated with the pathological subtypes, which were featured by lower SUVmax in the SN2 of the squamous carcinoma, and longer diameter of SN2 in the adenocarcinoma patients.</description><subject>Adenocarcinoma</subject><subject>Biomedical research</subject><subject>Biotechnology & Applied Microbiology</subject><subject>Life Sciences & Biomedicine</subject><subject>Lung cancer</subject><subject>Lymphatic system</subject><subject>Medical imaging</subject><subject>Medicine, Research & Experimental</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Multivariate analysis</subject><subject>Non-small cell lung carcinoma</subject><subject>Pathogenesis</subject><subject>Positron emission tomography</subject><subject>Research & Experimental Medicine</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Science & Technology</subject><subject>Small cell lung carcinoma</subject><subject>Statistical analysis</subject><subject>Subgroups</subject><subject>Tumors</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>AOWDO</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkk9v1DAQxSMEotXSG2dkiQsSDbU9SexckFAoBbEUpG25Rk4y6bok9mI7bPsV-NR4_2grOGFZsiX_5mme3yTJc0bfMJbnZ5xyelbyUkIuHyXHHFiWFixjjw93gKPkxPtbGpdkBS2Lp8kR8IxTkNlx8ruyzuGggraGNBjWiIYsfugVueTkCwbl40ZPlOnI4vr7qO5OydyaG_JeqxEDOmJ7cjWN1p1umc-6EOT8buXQ-42kNuRbFEcTPFnrsCSX1qSLUQ1DWuEwkPkUtSplWnTPkie9Gjye7M9Zcv3h_Kr6mM6_Xnyq3s1ThEKGVHJaCNpxEC2ilBSLrkMJQHkbLbe9aKDvgEMGrEcloRB9p7JMKJ43VBQNzJK3O93V1IzYtbE3p4Z65fSo3H1tla7_fjF6Wd_YX7XglAkBUeDVXsDZnxP6UI_at9GNMmgnX_OMZiA5xFRmyct_0Fs7ORPtbSjKRSZYGSm5o9bY2N638btaPDQUg8sBeJmX2wwrHbZpVXYyIZa-_v_SB3qpTafW-gAyWm_mqd7MU72fp0i_2NEYGezVA81A0lzAH5blwfU</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Jun, Zhao</creator><creator>Long-bao, Xu</creator><creator>Ming-ya, Peng</creator><creator>Jian, Wang</creator><creator>Shao, Guoqiang</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>Hindawi Publishing Group</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3277-6933</orcidid><orcidid>https://orcid.org/0000-0003-0262-3394</orcidid></search><sort><creationdate>2020</creationdate><title>Correlation between Skip N2 Metastases and SUVmax, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer</title><author>Jun, Zhao ; Long-bao, Xu ; Ming-ya, Peng ; Jian, Wang ; Shao, Guoqiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e368t-820670d237cee880e6dde83302c231cf7b3fd323431fea8367fda447a25b076b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma</topic><topic>Biomedical research</topic><topic>Biotechnology & Applied Microbiology</topic><topic>Life Sciences & Biomedicine</topic><topic>Lung cancer</topic><topic>Lymphatic system</topic><topic>Medical imaging</topic><topic>Medicine, Research & Experimental</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Multivariate analysis</topic><topic>Non-small cell lung carcinoma</topic><topic>Pathogenesis</topic><topic>Positron emission tomography</topic><topic>Research & Experimental Medicine</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Science & Technology</topic><topic>Small cell lung carcinoma</topic><topic>Statistical analysis</topic><topic>Subgroups</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jun, Zhao</creatorcontrib><creatorcontrib>Long-bao, Xu</creatorcontrib><creatorcontrib>Ming-ya, Peng</creatorcontrib><creatorcontrib>Jian, Wang</creatorcontrib><creatorcontrib>Shao, Guoqiang</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jun, Zhao</au><au>Long-bao, Xu</au><au>Ming-ya, Peng</au><au>Jian, Wang</au><au>Shao, Guoqiang</au><au>Kafle, Kumud K.</au><au>Kumud K Kafle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation between Skip N2 Metastases and SUVmax, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer</atitle><jtitle>BioMed research international</jtitle><stitle>BIOMED RES INT-UK</stitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><artnum>9298358</artnum><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Background. We aim at investigating the correlation between skip N2 metastases (SN2) and SUVmax, long diameter of tumor mass after 18F-FDG PET/CT, and pathological Ki67 expression in patients with non-small-cell lung cancer (NSCLC). Methods and Results. We retrospectively analyzed the factors that might affect the pathogenesis of SN2 in these patients. The clinical SN2 symptoms in patients with squamous carcinoma or adenocarcinoma were investigated. The work curve was utilized to analyze the optimal cutoff value for the SUVmax and long diameter of tumor. Multivariate analysis revealed that high expression of Ki67 was a risk factor for mediastinal SN2 (OR=1.042, 95% CI: 1.009-1.076). Subgroup analysis indicated that the SUVmax of the non-SN2 group was significantly higher than that of the SN2 group in patients with squamous carcinoma (16.3±6.0 vs. 10.7±5.6, P=0.026). In the patients with adenocarcinoma, the long diameter of tumor in the SN2 group was significantly longer than that of the non-SN2 group (43.8±16.3 mm vs. 30.1±13.8 mm, P=0.032). The Ki67 expression in the SN2 group was significantly higher than that of the non-SN2 group (51.7±24.0 vs. 30.0±19.2, P=0.028). Conclusions. The differences of clinical features of the patients in the SN2 group and non-SN2 group in the NSCLC patients were associated with the pathological subtypes, which were featured by lower SUVmax in the SN2 of the squamous carcinoma, and longer diameter of SN2 in the adenocarcinoma patients.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>32420384</pmid><doi>10.1155/2020/9298358</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-3277-6933</orcidid><orcidid>https://orcid.org/0000-0003-0262-3394</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2314-6133 |
| ispartof | BioMed research international, 2020, Vol.2020 (2020), p.1-7, Article 9298358 |
| issn | 2314-6133 2314-6141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2404382398 |
| source | PubMed Central Open Access; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection |
| subjects | Adenocarcinoma Biomedical research Biotechnology & Applied Microbiology Life Sciences & Biomedicine Lung cancer Lymphatic system Medical imaging Medicine, Research & Experimental Metastases Metastasis Multivariate analysis Non-small cell lung carcinoma Pathogenesis Positron emission tomography Research & Experimental Medicine Risk analysis Risk factors Science & Technology Small cell lung carcinoma Statistical analysis Subgroups Tumors |
| title | Correlation between Skip N2 Metastases and SUVmax, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T19%3A32%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20between%20Skip%20N2%20Metastases%20and%20SUVmax,%20Long%20Diameter%20of%20Tumor,%20and%20Ki67%20Expression%20in%20Patients%20with%20Non-Small-Cell%20Lung%20Cancer&rft.jtitle=BioMed%20research%20international&rft.au=Jun,%20Zhao&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.artnum=9298358&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2020/9298358&rft_dat=%3Cproquest_webof%3E2400274719%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2400274719&rft_id=info:pmid/32420384&rfr_iscdi=true |